Morning Movers: Stellantis skids following FY24 guidance cut

Check out this morning’s top movers from around Wall Street, compiled by The Fly. 

HIGHER –

• TTEC Holdings (TTEC) up 40% after receiving a non-binding proposal letter from TTEC founder, chairman and CEO Kenneth Tuchman, to take the company private at a proposed purchase price of $6.85 per share
• Prime Medicine (PRME) up 17% after announcing a strategic research collaboration and license agreement with Bristol Myers Squibb (BMY) to develop reagents for the next generation of ex vivo T-cell therapies
• Nio (NIO) up 14% after entering into definitive agreements for investment in NIO Holding, a PRC subsidiary in which it holds 92.1% controlling equity interest, with Hefei Jianheng New Energy Automobile Investment Fund Partnership, Anhui Provincial Emerging Industry Investment, and CS Capital, pursuant to which the strategic investors will invest an aggregate of RMB3.3B in cash to subscribe for newly issued shares of NIO China
• CVS Health (CVS) up 3% after The Wall Street Journal reported Glenview Capital will meet top executives of the company on Monday to propose ways the struggling healthcare company can improve its operations, the potential start of an activist stance by the fund
• AT&T (T) up 1% after announcing an agreement to sell its remaining stake in DIRECTV to TPG
• AudioEye (AEYE) up 1% after acquiring ADA Site Compliance and raising its FY24 guidance

DOWN AFTER EARNINGS –

• Addex Therapeutics (ADXN) down 10%

LOWER –

• Stellantis (STLA) down 13% after cutting its full-year outlook